were 67/45 and 47/39, respectively (p¼0.47). Intact PTH was measured in plasma. The redox couple of cysteine (Cys) in plasma was employed as a dynamic measure of systemic redox status. Cys redox ratio was defined as the concentration ratio of free reduced and free oxidized redox species. RESULTS:
Patients (n¼ 112)

Controls (n¼ 86)
Oxidised free Cys (mmol/L) 101 6 23 79 6 12 p < 0.0001 Cys redox ratio (mM/mM) 0.09 6 0.03 0.12 6 0.05 p < 0.0001 PTH (pmol/L) 9.4 6 8.2 6.3 6 1.7 p ¼ 0.001 GFR (ml/min/1.73m^2) 65 6 27 91 6 14 p < 0.0001
In the patient group, PTH had a linear relationship to oxidized free Cys and to Cys redox ratio. 
INTRODUCTION AND AIMS:
Zinc is usually absorbed from duodenum and upper jejunum and mainly excreted from the digestive tract and kidney. This nutrients is distributed throughout the body such as skeletal muscle, bone, skin, liver, brain and kidney, and more than 3,000 kinds of zinc containing proteins have physiologically important functions. But Patients with CKD are expected to lack this essenntial nutrients due to dietary restriction for renal protection and decreased appetite from uremia. Hence, We hypothesize that there is a relationship between nutritional status and zinc deficiency. The aim of our research is to clarify the prevalence zinc deficiency and the relationship between zinc deficiency and nutritional status in CKD patients. METHODS: 2252 patients without taking zinc containing drugs was examined their serum zinc concentration, renal function and nutritional status simultaneously from Oct. 1st 2007 to Sep. 31th 2017. We divide zinc level into three categories according to the serum zinc concentration, overt zinc deficiency(OZD): serum zinc consentration<60lg/ dl, potiontial zinc deficitency(PZD): 60Ϲserum zinc consentration<80lg/dl, normal zinc concerntration(NZC)м80lg/dl.The renal function is reported by eGFRcr, and nutritional status is assessed by the CONUT(controlling nutritional status) score. The CONUT score is an indicator of nutritional status calculated from serum albumin concentration, lymphocyte count and total cholesterol value(table-2).
RESULTS:
The clinical background of the three categories according to serum zinc level is as shown in Table 1 . There are 1055 patients of OZD, 855 patients of PZD, 342 patients of NZC. OZD which usually require treatment, are frequently as high as 38.0%. eGFRcr (ml/min/1.73m^2) correlated with the extent of zinc deficiency(NZC;62.4, PZD:60.8,OZD:45.3 (P<0.01)). In addition serum zinc level decreased with progress of CKD( figure-1, 2) . The CONUT score as an indicator of malnutrition tend to rise with progress of CKD, and as the CONUT score increases, the frequency of zinc deficiency increases( figure-3,4) .Protein catabolic rate(PCR) is measured as an indicator of dietary intake of protein in 25 peritoneal dialysis patients. Serum ALB and zinc value are well correlated with PCR. Oral intake of nutrients may affect serum zinc concentration. CONCLUSIONS: Zinc deficiency is associated with nutritional status. In ptatients with CKD, malnutrition is common condition. Hence the prevalence of zinc deficiency is also high. Nephrologists force CKD patients to restrict diet for renal protection, but dietary restriction itself may cause zinc deficiency. We should recognize that malnutrition and CKD are the risk factors of zinc deficiency. 
SP388 THE DECREASE IN PHOSPHATE INTAKE IMPROVES ENDOTHELIAL FUNCTION IN PRE-DIALYSIS CKD PATIENTS
INTRODUCTION AND AIMS:
Chronic kidney disease (CKD) is a powerful risk factor for cardiovascular (CV) risk and mortality. Disturbances in phosphate homeostasis have been associated with CV events and death, particularly among individuals with CKD. Although hyperphosphatemia has been recognized as an important factor involved in uremic vasculopathy by inducing vascular calcification through the differentiation of vascular smooth muscle cells to osteoblast-like cells, the role of phosphate homeostasis on endothelial dysfunction (ED) in CKD is less clear.We aimed to investigate the influence of a low phosphate diet on endothelial function in a pre-dialysis CKD population. METHODS: Fifteen pre-dialysis CKD patients (10M:5F), aged 59615 years, presenting an estimated GFR of 49,2634,2ml/min/1,73m2 (CKD-Epi) and Charlson index of 563 were recruited. Patients were evaluated during basal phosphate intake (BPi) and after a 14 day period of a low phosphate diet including 700 mg/day (LPi). Dietary Pi intake was assessed during BPi using a semiquantitative food frequency questionnaire, validated for the adult population. Endothelial function (Reactive Hyperemia Index, Endopath 2000) as well as blood levels of circulating endothelial cells (CECs) and progenitor endothelial cells (EPCs) were assessed in both BPi and LPi periods. RESULTS: Mean daily phosphate intake during BPi was 11226256mg. No significant differences were observed in phosphate serum levels between BPi and LPi periods (3.5760.63 vs 3.4860.57, p¼0.520); in addition, both FGF23 and PTHi serum levels did not differ between BPi and LPi periods (FGF23, 2956104 vs 214661 pg/ml, p¼0.73; PTHi, 92.5659.6 vs 86.8639.8 pg/ml, p¼0.91); moreover, EPCs blood levels did not differ between the two periods (BPi, 1.8Â10-362Â10-4, LPi, 1.7Â10-363Â10-4, p¼0.85). However, endothelial function was significantly improved during LPi in comparison with BPi (1.760.4 vs 2.160.6; p<0.05) and this was accompanied by a non-significant decrease in CECs blood levels during LPi (5.8Â10-369Â10-4 vs. 3.5Â10-364Â10-4, p¼0.06). CONCLUSIONS: Notwithstanding the reduced number of patients studied, our preliminary results strongly suggest that low phosphate intake contributes to improve ED in pre-dialysis CKD patients. 
